Insider · CIK 0001557420
Craig Fraser
Files at WINT (WINDTREE THERAPEUTICS INC /DE/). First filing Apr 26, 2023, latest Oct 9, 2024.
In brief
Craig Fraser files SEC Form 4 as CEO, president and director at WINT (WINDTREE THERAPEUTICS INC /DE/). Since Apr 26, 2023, Craig Fraser has reported 3 open-market buys worth $10k and 0 open-market sells worth $0, the latest filed on Oct 9, 2024.
A track record needs three past buys with six months of prices behind them; Craig Fraser has 1, so none is measured yet.
The newest scored trade: bought $4,942 of WINT on Oct 8, 2024, filed Oct 9, 2024, scored 53 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
WINT: WINDTREE THERAPEUTICS INC /DE/
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 53Moderate | WINTbuy WINDTREE THERAPEUTICS INC /DE/ | $4,942 5,431 shares | +169% | 0% from low-96% from high | |
| 54Moderate | WINTbuy WINDTREE THERAPEUTICS INC /DE/ | $2,650 1,497 shares | +27% | 0% from low-95% from high | |
| 49Moderate | WINTbuy WINDTREE THERAPEUTICS INC /DE/ | $2,485 1,315 shares | +31% | 0% from low-95% from high |
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 8, 2024 | WINT WINDTREE THERAPEUTICS INC /DE/ | POpen-market purchase Common Stock | +5,431 | $0.91 | $4,942 | 8,638 | Oct 9, 2024 |
| Jul 22, 2024 | WINT WINDTREE THERAPEUTICS INC /DE/ | AGrant or award Series C Preferred Stockderivative | +19 | - | - | 19 | Jul 24, 2024 |
| Jul 22, 2024 | WINT WINDTREE THERAPEUTICS INC /DE/ | AGrant or award Warrants (Right to Buy)derivative | +4,011 | - | - | 4,011 | Jul 24, 2024 |
| Apr 26, 2023 | WINT WINDTREE THERAPEUTICS INC /DE/ | POpen-market purchase Common Stock | +1,497 | $1.77 | $2,650 | 7,010 | Apr 27, 2023 |
| Apr 25, 2023 | WINT WINDTREE THERAPEUTICS INC /DE/ | POpen-market purchase Common Stock | +1,315 | $1.89 | $2,485 | 5,513 | Apr 26, 2023 |
| Feb 28, 2023 | WINT WINDTREE THERAPEUTICS INC /DE/ | FTax withholding Common Stock | -334 | $0.00 | $0 | 4,198 | Mar 2, 2023 |
Questions about Craig Fraser
Answered from the filings on this page, as of the latest one.
Is Craig Fraser buying or selling?
Not in the last 12 months. Craig Fraser's latest open-market trade on SEC Form 4 was bought $4,942 of WINT on Oct 8, 2024.
How did Craig Fraser's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Craig Fraser has 1.
Where does Craig Fraser file Form 4?
Craig Fraser has filed Form 4 at WINT (WINDTREE THERAPEUTICS INC /DE/) as President and CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.